SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (354)8/3/1999 3:20:00 PM
From: michael modeme  Read Replies (1) | Respond to of 3044
 
Well, the distinction between sales and revenues is rather vague. My point was that the amount of money coming into the company as a ratio to the market cap is rather low in myÊopinion. As for INCY, I already own it. But I do prefer MLNM over INCY in that their bioinf. position is stronger, they have more expertise in computational bioinformatics and statistical analyses of gene expression.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News